(Q41912925)

14 October 2017

Reduced in-vitro susceptibility to mefloquine in West African isolates of Plasmodium falciparum (English)

1 reference

14 October 2017

Plasmodium falciparum

0 references

1 reference

A M Oduola

1

1 reference

14 October 2017

W K Milhous

2

1 reference

14 October 2017

L A Salako

3

1 reference

14 October 2017

O Walker

4

1 reference

14 October 2017

R E Desjardins

5

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 December 1987

1 reference

14 October 2017

1 reference

14 October 2017

2

1 reference

14 October 2017

8571

1 reference

14 October 2017

1304-1305

1 reference

Chloroquine-resistant Plasmodium falciparum in Cameroon.

14 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991195-0

7 January 2021

Chloroquine-resistant falciparum malaria in Benin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991195-0

7 January 2021

Plasmodium falciparum infection not responding to chloroquine in Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991195-0

7 January 2021

Single dose kinetics of mefloquine in man. Plasma levels of the unchanged drug and of one of its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991195-0

7 January 2021

Kinetics of a new antimalarial, mefloquine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991195-0

7 January 2021

Mefloquine (WR 142,490) in the Treatment of Human Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991195-0

7 January 2021

The chemotherapy of rodent malaria, XXXI. The effect of some metabolic inhibitors upon chloroquine-induced pigment clumping (CIPC) inPlasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991195-0

7 January 2021

Mefloquine, a clinically useful quinolinemethanol antimalarial which does not significantly bind to DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991195-0

7 January 2021

Type II mefloquine resistance in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991195-0

7 January 2021

RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991195-0

7 January 2021

Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991195-0

7 January 2021

Plasmodium falciparum malaria and intravenous quinidine gluconate.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2991195-0

7 January 2021

10.1016/S0140-6736(87)91195-0

Identifiers

DOI

1 reference

release_mi46hvhwffcudiiy34kia2ztk4

14 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mi46hvhwffcudiiy34kia2ztk4

24 November 2022

mapped directly with Wikidata item

1 reference